Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery.

Abstract

Cyclin-dependent kinase 12 (CDK12) is a member of the CDK family of proteins (CDK) and is critical for cancer development. Years of study into CDK12 have generated much information regarding the intricacy of its function and mechanism as well as inhibitors against it for oncological research. However, there remains a lack of understanding regarding the role of CDK12 in carcinogenesis and cancer prevention. An exhaustive comprehension of CDK12 will highly stimulate the development of new strategies for treating and preventing cancer. Here, we review the literature of CDK12, with a focus on its function, its role in signaling, and how to use it as a target for discovery of novel drugs for cancer prevention and therapy.

• Authors: Hui Liu, Kangdong Liu, Zigang Dong
• Journal: Cancer research (Cancer Res) Vol. 81 Issue 1 Pg. 18-26 (01 01 2021) ISSN: 1538-7445 [Electronic] United States
• PMID: 32958547 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: ©2020 American Association for Cancer Research.

Chemical References

• Antineoplastic Agents
• CDK12 protein, human
• Cyclin-Dependent Kinases

Topics

• Antineoplastic Agents (therapeutic use)
• Cyclin-Dependent Kinases (antagonists & inhibitors)
• Drug Discovery
• Humans
• Molecular Targeted Therapy
• Neoplasms (drug therapy, metabolism, pathology)
• Signal Transduction